Search alternatives:
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
13601
-
13602
-
13603
Key safety measures including adverse events.
Published 2025“…<div><p>Background</p><p>The risk-to-benefit ratio of using combined oral contraceptive pills (COCPs) and/or metformin for comprehensive management of polycystic ovary syndrome (PCOS) in women with obesity is unclear. As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.…”
-
13604
-
13605
-
13606
-
13607
-
13608
-
13609
-
13610
-
13611
The Numerical data used in all figures.
Published 2023“…However, the mechanism on how AJ01 breaks the AjTmod-stabilized cytoskeleton for internalization remains unclear. Here, we identified a novel AJ01 Type III secretion system (T3SS) effector of leucine-rich repeat-containing serine/threonine-protein kinase (STPKLRR) with five LRR domains and a serine/threonine kinase (STYKc) domain, which could specifically interact with tropomodulin domain of AjTmod. …”
-
13612
Primers.
Published 2023“…However, the mechanism on how AJ01 breaks the AjTmod-stabilized cytoskeleton for internalization remains unclear. Here, we identified a novel AJ01 Type III secretion system (T3SS) effector of leucine-rich repeat-containing serine/threonine-protein kinase (STPKLRR) with five LRR domains and a serine/threonine kinase (STYKc) domain, which could specifically interact with tropomodulin domain of AjTmod. …”
-
13613
-
13614
Image1_Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib.TIF
Published 2021“…The combination of SLC1A5 inhibitor V9302 and Almonertinib had a synergistic inhibitory effect on the proliferation of NSCLC. …”
-
13615
-
13616
-
13617
-
13618
Ab Initio Study of the Substituent Effects on the Relative Stability of the <i>E</i> and <i>Z</i> Conformers of Phenyl Esters. Stereoelectronic Effects on the Reactivity of the Car...
Published 2005“…ED/EW substituents adjust the availability of the π*<sub>C</sub><sub></sub><sub>O</sub> antibonding orbital to interact with the lone pair orbital of the attacking nucleophile and therefore affect the reactivity: EW substituents increase and ED substituents decrease it. Excellent correlations were observed between the rate coefficients of nucleophilic acyl substitutions and π*<sub>C</sub><sub></sub><sub>O</sub> occupancies of the ester series <b>4 </b>and <b>5</b>.…”
-
13619
Maternal exposure to U-46619 decreases fetal body weight at E19 compared to sham pups.
Published 2016“…<p>Pregnant mice were exposed to a TXA<sub>2</sub>- analog (U-46619) or vehicle via micro-osmotic pump infusion from E12.5 until birth (term ~20 days). …”
-
13620
Three New Phases in the K/Cu/Th/S System: KCuThS<sub>3</sub>, K<sub>2</sub>Cu<sub>2</sub>ThS<sub>4</sub>, and K<sub>3</sub>Cu<sub>3</sub>Th<sub>2</sub>S<sub>7</sub>
Published 2005“…All three phases are semiconductors with optical band gaps of 2.95, 2.17, and 2.49 eV(<b>I</b>−<b>III</b>). Compound <b>I</b> crystallizes in the orthorhombic space group <i>Cmcm</i> with <i>a </i>= 4.076(1) Å, <i>b</i> = 13.864(4) Å, and <i>c</i> = 10.541(3) Å. …”